Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,437

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study

QUASAR Collaborative Group·2007·The Lancet
DOI 10.1016/s0140-6736(07)61866-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61866-2

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 33

  1. Moertel, 1990, Levamisole and fluorouracil as adjuvant therapy of resected colon carcinoma, N Engl J Med, 322, 352, 10.1056/NEJM199002083220602 · DOI · Paper page
  2. Taal, 2001, Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III, Br J Cancer, 85, 1437, 10.1054/bjoc.2001.2117 · DOI · Paper page
  3. 1990, Cancer of the colon and rectum consensus statement, Brit J Surg, 77, 1063, 10.1002/bjs.1800770936 · doi:10.1002/bjs.1800770936
  4. 1990, NIH Consensus Conference: adjuvant cancer therapy, JAMA, 264, 1444, 10.1001/jama.264.11.1444 · doi:10.1001/jama.264.11.1444 · Paper page
  5. Francini, 1994, Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer, Gastroenterology, 106, 899, 10.1016/0016-5085(94)90748-X · DOI · Paper page
  6. 1995, Efficacy of adjuvant fluorouracil and folinic acid in colon cancer, Lancet, 345, 939, 10.1016/S0140-6736(95)90696-7 · DOI · Paper page
  7. O'Connell, 1997, Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as post-operative adjuvant therapy for colon cancer, J Clin Oncol, 15, 246, 10.1200/JCO.1997.15.1.246 · DOI · Paper page
  8. Wolmark, 1993, The benefit of leucovorin modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03, J Clin Oncol, 11, 1879, 10.1200/JCO.1993.11.10.1879 · DOI · Paper page
  9. Wolmark, 1999, J Clin Oncol, 17, 3553, 10.1200/JCO.1999.17.11.3553 · DOI · Paper page
  10. O'Connell, 1998, Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer, J Clin Oncol, 16, 295, 10.1200/JCO.1998.16.1.295 · DOI · Paper page
  11. Haller, 2005, Phase III study of fluorouracil, leucovorin, and levamisole (LEV) in high-risk stage II and III colon cancer: final report of Intergroup 0089, J Clin Oncol, 23, 8671, 10.1200/JCO.2004.00.5686 · DOI · Paper page
  12. 2000, Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial, Lancet, 355, 1588, 10.1016/S0140-6736(00)02214-5 · DOI · Paper page
  13. Kerr, 1989, 5-fluorouracil and folinic acid: interesting biochemistry or effective treatment?, Br J Cancer, 60, 807, 10.1038/bjc.1989.370 · doi:10.1038/bjc.1989.370
  14. 2004, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis, J Clin Oncol, 22, 3766, 10.1200/JCO.2004.03.104 · DOI · Paper page
  15. Benson, 2004, American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer, J Clin Oncol, 22, 3408, 10.1200/JCO.2004.05.063 · DOI · Paper page
  16. Krook, 1991, Effective surgical adjuvant therapy for high-risk rectal carcinoma, N Engl J Med, 324, 709, 10.1056/NEJM199103143241101 · DOI · Paper page
  17. Zittoun, 1991, Comparative effect of 6S,6R and 6RS leucovorin on methotrexate rescue and modulation of 5-fluorouracil, Br J Cancer, 63, 885, 10.1038/bjc.1991.194 · doi:10.1038/bjc.1991.194
  18. Kerr, 2000, Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules—less pain, same gain, Ann Oncol, 11, 947, 10.1023/A:1008303229469 · DOI
  19. Davidson-Homewood, 2003, Development of a disease specific questionnaire to supplement a generic tool for QoL in colorectal cancer, Psychooncology, 12, 675, 10.1002/pon.684 · doi:10.1002/pon.684
  20. Melville, 1998, Management of colorectal cancer, Qual Health Care, 7, 103, 10.1136/qshc.7.2.103 · DOI
  21. Mamounas, 1999, Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04), J Clin Oncol, 17, 1349, 10.1200/JCO.1999.17.5.1349 · DOI · Paper page
  22. Gill, 2004, Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: what benefits and by how much?, J Clin Oncol, 22, 1797, 10.1200/JCO.2004.09.059 · DOI · Paper page
  23. Glimelius, 2005, Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group, Acta Oncologica, 44, 904, 10.1080/02841860500355900a · DOI
  24. Figueredo, 2004, Adjuvant therapy for stage II colon cancer: a systematic review from the cancer care on Ontario program in evidence-based care's gastrointestinal cancer disease site group, J Clin Oncol, 22, 3395, 10.1200/JCO.2004.03.087 · DOI · Paper page
  25. Smith, 2004, Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP Protocol C-01, J Natl Cancer Inst, 96, 1128, 10.1093/jnci/djh220 · DOI
  26. Sargent, 2001, A pooled analysis of adjuvant chemotherapy for resected colorectal cancer in elderly patients, N Engl J Med, 345, 1091, 10.1056/NEJMoa010957 · DOI · Paper page
  27. Goldberg, 2006, Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer, J Clin Oncol, 24, 4085, 10.1200/JCO.2006.06.9039 · DOI · Paper page
  28. Jansen, 2004, Review of determinants of patients' preferences for adjuvant therapy in cancer, J Clin Oncol, 22, 3181, 10.1200/JCO.2004.06.109 · doi:10.1200/jco.2004.06.109
  29. Twelves, 2005, Capecitabine as adjuvant treatment for stage III colon cancer, N Engl J Med, 352, 2696, 10.1056/NEJMoa043116 · DOI · Paper page
  30. André, 2004, Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer, N Engl J Med, 350, 2343, 10.1056/NEJMoa032709 · DOI · Paper page
  31. Wolmark, 2005, A phase III trial comparing FULV to FULV + oxaliplatin in stage II or II carcinoma of the colon: results of NSABP protocol C-07, Proc Am Soc Clin Oncol, 23, 16S
  32. Schmoll, 2007, Phase II trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients, J Clin Oncol, 25, 102, 10.1200/JCO.2006.08.1075 · DOI · Paper page
  33. Smith, 2003, The occurrence of severe enteropathy among patients with stage II/III resected colon cancer (CC) treated with 5-FU/leucovorin (FL) plus oxaliplatin (FLOX), Proc Am Soc Clin Oncol, 22, 294

Cited by

See all 1,437

Metadata

Authors
QUASAR Collaborative Group
Venue
The Lancet
Publisher
Elsevier BV
Published
2007-12
Volume
370
Issue
9604
Pages
2020-2029
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(07)61866-2
OpenAlex
W2109740395
Cited by
1,437
References
3
FWCI
28.52
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. https://app.cochat.ai/papers/10.1016/s0140-6736(07)61866-2
The paper
QUASAR Collaborative Group. (2007). Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. The Lancet. https://doi.org/10.1016/s0140-6736(07)61866-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.